Correlation Between Cingulate and Anebulo Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Cingulate and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cingulate and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Cingulate and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate and Anebulo Pharmaceuticals.

Diversification Opportunities for Cingulate and Anebulo Pharmaceuticals

0.14

Correlation Coefficient

Cingulate  Anebulo Pharmaceuticals

Average diversification

The 3 months correlation between Cingulate and Anebulo is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Cingulate is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Cingulate i.e., Cingulate and Anebulo Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cingulate and Anebulo Pharmaceuticals

Given the investment horizon of 90 days Cingulate is expected to generate 0.46 times more return on investment than Anebulo Pharmaceuticals. However, Cingulate is 2.17 times less risky than Anebulo Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest  452.00  in Cingulate on February 3, 2025 and sell it today you would lose (20.00) from holding Cingulate or give up 4.42% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cingulate  vs.  Anebulo Pharmaceuticals

Cingulate

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cingulate has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Cingulate is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Anebulo Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in June 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Cingulate and Anebulo Pharmaceuticals

The main advantage of trading using opposite Cingulate and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.

The idea behind Cingulate and Anebulo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.